Daniel de Iracema Gomes Cubero

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 898 citations

Medicine, Oncology, Pharmacology +14

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

Cora N. Sternberg, Karim Fizazi, Fred Saad et al. · New England Journal of Medicine · 2020 · 422 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Gabapentin for the prevention of chemotherapy- induced nausea and vomiting: a pilot study

Felipe Melo Cruz, Daniel de Iracema Gomes Cubero, Patrícia Taranto et al. · Supportive Care in Cancer · 2011 · 53 citations

Medicine, Pharmacology, Pharmacotherapy +12

Vitamin E for prevention of oxaliplatin-induced peripheral neuropathy: a pilot randomized clinical trial

Samuel Oliveira de Afonseca, Felipe Melo Cruz, Daniel de Iracema Gomes Cubero et al. · Sao Paulo Medical Journal · 2013 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17

“Burnout in Medical Oncology Fellows: a Prospective Multicenter Cohort Study in Brazilian Institutions”

Daniel de Iracema Gomes Cubero, Renata Rego Lins Fumis, Thiago Hérick de Sá et al. · Journal of Cancer Education · 2015 · 46 citations · Full text

Medicine, Medical Education, Oncology +11